References
- Kilcline C, Frieden IJ. Infantile hemangiomas: how common are they? A systematic review of the medical literature. Pediatr Dermatol. 2008;25(2):168–173.
- Kanada KN, Merin MR, Munden A, et al. A prospective study of cutaneous findings in newborns in the United States: correlation with race, ethnicity, and gestational status using updated classification and nomenclature. J Pediatr. 2012;161(2):240–245.
- Lin Ma, Hui Chen, Jiawei Zheng, et al. Guidelines for diagnosis and treatment of hemangiomas and vascular malformations (2016 edition). J Tissue Eng Reconstr Surg. 2016;02:63–93 + 97.
- Tollefson MM, Frieden IJ. Early growth of infantile hemangiomas: what parents’ photographs tell us. Pediatrics. 2012;130(2):e314–e320.
- Chang LC, Haggstrom AN, Drolet BA, et al. Growth characteristics of infantile hemangiomas: implications for management. Pediatrics. 2008;122(2):360–367.
- Luu M, Frieden IJ. Haemangioma: clinical course, complications and management. Br J Dermatol. 2013;169(1):20–30.
- Wassef M, Blei F, Adams D, et al. Vascular anomalies classification: recommendations from the international society for the study of vascular anomalies. Pediatrics. 2015;136(1):e203–214.
- Painter SL, Hildebrand GD. Review of topical beta blockers as treatment for infantile hemangiomas. Surv Ophthalmol. 2016;61(1):51–58.
- Achauer BM, Chang CJ, Vander Kam VM. Management of hemangioma of infancy: review of 245 patients. Plast Reconstr Surg. 1997;99(5):1301–1308.
- Janmohamed SR, de Waard-van der Spek FB, Madern GC, et al. Scoring the proliferative activity of haemangioma of infancy: the Haemangioma Activity Score (HAS). Clin Exp Dermatol. 2011;36(7):715–723.
- Rouhana HF, Fruge JH, Massengale WT. Beta blocker treatment for infantile hemangiomas. Dermatol Online J. 2015;21(7).
- Xue K, Hildebrand GD. Deep periocular infantile capillary hemangiomas responding to topical application of timolol maleate, 0.5%, drops. JAMA Ophthalmol. 2013;131(9):1246–1248.
- Leaute-Labreze C, Dumas de la Roque E, Hubiche T, et al. Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008;358(24):2649–2651.
- Xu DP, Cao RY, Tong S, et al. Topical timolol maleate for superficial infantile hemangiomas: an observational study. J Oral Maxillofac Surg. 2015;73(6):1089–1094.
- Painter SL, Hildebrand GD. Topical timolol maleate 0.5% solution for the management of deep periocular infantile hemangiomas. J AAPOS. 2016;20(2):172–174.e171.
- Sorrell J, Chamlin SL. Topical timolol 0.5% gel-forming solution for small deep facial infantile hemangiomas. Pediatr Dermatol. 2013;30(5):592–594.
- Nelson JS, McCullough JL, Glenn TC, et al. Mid-infrared laser ablation of stratum corneum enhances in vitro percutaneous transport of drugs. J Invest Dermatol. 1991;97(5):874–879.
- Xiang L, Zhou Z. Principles and techniques of laser skin treatment. Beijing: People’s Medical Publishing House; 2014. p. 43–45.
- Ma G, Wu P, Lin X, et al. Fractional carbon dioxide laser-assisted drug delivery of topical timolol solution for the treatment of deep infantile hemangioma: a pilot study. Pediatr Dermatol. 2014;31(3):286–291.
- McMahon P, Oza V, Frieden IJ. Topical timolol for infantile hemangiomas: putting a note of caution in “cautiously optimistic”. Pediatr Dermatol. 2012;29(1):127–130.